Drug intelligence / Profile preview

sevelamer + sodium bicarbonate + sodium chloride

Development stage
Preclinical
Lead developer
Sanofi
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

This is a combination formulation containing sevelamer (typically as sevelamer carbonate), sodium bicarbonate, and sodium chloride. Sevelamer is a non-absorbed, calcium- and metal-free phosphate-binding polymer used to control hyperphosphatemia in patients with chronic kidney disease (CKD), especially those on dialysis. It acts by binding dietary phosphate in the gastrointestinal tract, thereby reducing its absorption and lowering serum phosphorus levels[4][6][8]. Sodium bicarbonate serves as an alkalinizing agent to help correct or prevent metabolic acidosis—a common complication in CKD—by increasing serum bicarbonate levels[7][8]. Sodium chloride may be included for tablet stability or to adjust electrolyte balance[7]. This specific combination aims to provide effective phosphate binding while minimizing the risk of metabolic acidosis that can occur with some other formulations of sevelamer.

02

Targets

Pi (Inorganic phosphate)Systemic and gastrointestinal bicarbonate buffer system

Beyond the preview

Go deeper on sevelamer + sodium bicarbonate + sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sevelamer + sodium bicarbonate + sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call